Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: A randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Infectious Diseases

Volumn 13, Issue 11, 2013, Pages 946-954

  Zanger, Philipp ^a   Nurjadi, Dennis ^a   Gabor, Julian ^a   Gaile, Marika ^a   Kremsner, Peter G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; QUINOLONE DERIVATIVE; RIFAXIMIN;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; INTERVENTION STUDY; LOOSE FECES; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTHEAST ASIA; TABLET; TRAVELLER DIARRHEA;

ADULT; ANTI-INFECTIVE AGENTS; ASIA, SOUTHEASTERN; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; RIFAMYCINS; TRAVEL; YOUNG ADULT;

EID: 84886895574     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70221-4     Document Type: Article

References (32)

1. Steffen R Epidemiology of traveler's diarrhea. Clin Infect Dis 2005, 41(suppl 8):S536-S540.
2. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006, 354:119-130.
3. Steffen R, van der Linde F, Gyr K, Schar M Epidemiology of diarrhea in travelers. JAMA 1983, 249:1176-1180.
4. Schwille-Kiuntke J, Frick JS, Zanger P, Enck P Post-infectious irritable bowel syndrome-a review of the literature. Z Gastroenterol 2011, 49:997-1003.
5. Pitzurra R, Fried M, Rogler G, et al. Irritable bowel syndrome among a cohort of European travelers to resource-limited destinations. J Travel Med 2011, 18:250-256.
6. Sack RB Prophylactic antimicrobials for traveler's diarrhea: an early history. Clin Infect Dis 2005, 41(suppl 8):S553-S556.
7. DuPont HL, Ericsson CD, Farthing MJ, et al. Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med 2009, 16:149-160.
8. Gorbach S, Edelman R Traverler's diarrhoea: National Instiutes of Health Consensus Development Conference. Rev Infect Dis 1986, 8(suppl 2):S109-S233.
9. Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006, 43:1499-1539.
10. Alajbegovic S, Sanders JW, Atherly DE, Riddle MS Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis. Syst Rev 2012, 1:39.
11. Jiang ZD, Ke S, Palazzini E, Riopel L, Dupont H In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother 2000, 44:2205-2206.
12. Koo HL, DuPont HL Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010, 26:17-25.
13. Hu Y, Ren J, Zhan M, Li W, Dai H Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials. J Travel Med 2012, 19:352-356.
14. Martinez-Sandoval F, Ericsson CD, Jiang ZD, et al. Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico. J Travel Med 2010, 17:111-117.
15. DuPont HL, Jiang ZD, Okhuysen PC, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005, 142:805-812.
16. Flores J, Dupont HL, Jiang ZD, et al. A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season. J Travel Med 2011, 18:333-336.
17. Armstrong AW, Ulukan S, Weiner M, et al. A randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of rifaximin for the prevention of travelers' diarrhea in US military personnel deployed to Incirlik Air Base, Incirlik, Turkey. J Travel Med 2010, 17:392-394.
18. Taylor DN, Bourgeois AL, Ericsson CD, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 2006, 74:1060-1066.
19. Taylor DN, McKenzie R, Durbin A, et al. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis 2006, 42:1283-1288.
20. Connor B Traveler's diarrhea chemoprophylaxis: an alternative recommendation. Clin Infect Dis 2008, 46:475-476.
21. DuPont HL Travelers' diarrhea: antimicrobial therapy and chemoprevention. Nat Clin Pract Gastroenterol Hepatol 2005, 2:191-198.
22. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
23. Altman DG, Andersen PK Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999, 319:1492-1495.
24. Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, Coutinho RA Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. Trop Med Int Health 1998, 3:896-903.
25. von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000, 356:133-134.
26. Parry H, Howard AJ, Galpin OP, Hassan SP The prophylaxis of travellers' diarrhoea; a double blind placebo controlled trial of ciprofloxacin during a Himalayan expedition. J Infect 1994, 28:337-338.
27. Wiström J, Norrby SR, Burman LG, Lundholm R, Jellheden B, Englund G Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother 1987, 20:563-574.
28. Echeverria P, Sack RB, Blacklow NR, Bodhidatta P, Rowe B, McFarland A Prophylactic doxycycline for travelers' diarrhea in Thailand. Further supportive evidence of Aeromonas hydrophila as an enteric pathogen. Am J Epidemiol 1984, 120:912-921.
29. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002, 8:175-180.
30. Tribble DR, Sanders JW, Pang LW, et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007, 44:338-346.
31. Shah N, DuPont HL, Ramsey DJ Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009, 80:609-614.
32. Sierra JM, Ruiz J, Navia MM, Vargas M, Vila J In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea. Antimicrob Agents Chemother 2001, 45:643-644.